This website is intended for US healthcare professionals only.
Contact Us
Contact BioCryst
Submit an Inquiry
Request a Grant or Sponsorship
Expanded-Access Program
Search Medical Information
Clinical Trials
Congresses
Publications
Disease State Information & Resources
Hereditary Angioedema (HAE)
Netherton Syndrome (NS)
Diabetic Macular Edema (DME)
Complement-Mediated Diseases
Clinical Trials
Congresses
Publications
Disease State Information & Resources
Hereditary Angioedema (HAE)
Netherton Syndrome (NS)
Diabetic Macular Edema (DME)
Complement-Mediated Diseases
Contact Us
Contact BioCryst
Submit an Inquiry
Request a Grant or Sponsorship
Expanded-Access Program
Search Medical Information
Small Molecule Drugs for Atopic Dermatitis, Rheumatoid Arthritis, and Hereditary Angioedema
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Considerations for Transition From Subcutaneous to Oral Prophylaxis in the Treatment of Hereditary Angioedema
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Attenuated Androgen Discontinuation in Patients with Hereditary Angioedema: a Commented Case Series
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Assessment and Management of Disease Burden and Quality of Life in Patients with Hereditary Angioedema: a Consensus Report
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Long-Term Prophylaxis in Hereditary Angioedema Management: Current Practices in France and Unmet Needs
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Shared Decision-Making in the Management of Hereditary Angioedema: An Analysis of Patient and Physician Perspectives
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Global Perceptions of the Current and Future Impacts of COVID-19 on Hereditary Angioedema Management
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Berotralstat (BCX7353) is a Novel, Oral Prophylactic Treatment for Hereditary Angioedema: Review of Phase II and III Studies
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Androgen Use in Hereditary Angioedema: A Critical Appraisal and Approaches to Transitioning from Androgens to Other Therapies
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Oral Berotralstat for the Prophylaxis of Hereditary Angioedema Attacks in Patients in Japan: A Phase 3 Randomized Trial
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Previous Page
1
2
3
4
5
6
Next Page